Pfizer is reportedly nearing an agreement to sell its infant nutrition business, with both Nestle and Danone linked to the deal. 

The US pharmaceutical company has previously confirmed to just-food that it is “considering strategic options” for the business, including a “sale, spin-off or other transaction”. 

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

According to a report in the Wall Street Journal, Pfizer has stuck an agreement to sell the unit to Nestle for US$9bn. Meanwhile, other reports have suggested that Nestle and Danone have both submitted competing bids, valuing the business at around $10bn. 

Pfizer is expected to announce a sale of the unit next week.  

Just Food Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Just Food Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now